{"AllianceGenome": "12014", "HGNC": "12014", "MIM": "187680", "_id": "7172", "_version": 1, "accession": {"genomic": ["AB045146.1", "AF035426.1", "AF039825.1", "AF039826.1", "AF039827.1", "AF039828.1", "AF039829.1", "AF060074.1", "AH006628.2", "AH006704.2", "AL589723.7", "CH471087.1", "CP068272.2", "NC_000006.12", "NC_060930.1", "NG_012137.3", "U81562.1", "U81563.1", "U81564.1", "U81565.1", "U81566.1", "U81567.1", "U81568.1", "U81569.1", "U81570.1", "U81571.1", "U81572.1", "U81573.1"], "protein": ["AAB27277.1", "AAB71625.1", "AAB71626.1", "AAB71627.1", "AAB71628.1", "AAB71629.1", "AAB71630.1", "AAB71631.1", "AAB71632.1", "AAB71633.1", "AAB71634.1", "AAB71635.1", "AAB71636.1", "AAB80746.1", "AAB80747.1", "AAC32289.1", "AAC50130.1", "AAC51865.1", "AAH05339.1", "AAH09596.1", "BAA97037.1", "EAW55393.1", "EAW55394.1", "EAW55395.1", "EAW55396.1", "EAW55397.1", "EAW55398.1", "EAW55399.1", "NP_000358.1", "NP_001333746.1", "NP_001333747.1", "P51580.1", "XP_047275245.1", "XP_047275246.1", "XP_054212273.1", "XP_054212274.1"], "rna": ["AA746081.1", "AA825975.1", "AF021876.1", "AF021877.1", "AK310420.1", "BC005339.1", "BC009596.1", "BI598325.1", "DB481604.1", "HY252883.1", "HY300307.1", "NM_000367.5", "NM_001346817.1", "NM_001346818.1", "S62904.1", "U12387.1", "XM_047419289.1", "XM_047419290.1", "XM_054356298.1", "XM_054356299.1"], "translation": [{"protein": "XP_047275246.1", "rna": "XM_047419290.1"}, {"protein": "AAB80747.1", "rna": "AF021877.1"}, {"protein": "AAB80746.1", "rna": "AF021876.1"}, {"protein": "AAC50130.1", "rna": "U12387.1"}, {"protein": "XP_054212273.1", "rna": "XM_054356298.1"}, {"protein": "AAB27277.1", "rna": "S62904.1"}, {"protein": "AAH09596.1", "rna": "BC009596.1"}, {"protein": "AAH05339.1", "rna": "BC005339.1"}, {"protein": "NP_001333746.1", "rna": "NM_001346817.1"}, {"protein": "NP_000358.1", "rna": "NM_000367.5"}, {"protein": "NP_001333747.1", "rna": "NM_001346818.1"}, {"protein": "XP_047275245.1", "rna": "XM_047419289.1"}, {"protein": "XP_054212274.1", "rna": "XM_054356299.1"}]}, "alias": "TPMTD", "ec": "2.1.1.67", "ensembl": {"gene": "ENSG00000137364", "protein": "ENSP00000312304", "transcript": "ENST00000309983", "translation": [{"protein": "ENSP00000312304", "rna": "ENST00000309983"}], "type_of_gene": "protein_coding"}, "entrezgene": "7172", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 11.94043645, "exp_mis": 74.1875707, "exp_syn": 30.936149, "lof_z": 1.12959821810589, "mis_z": -0.159710157867985, "mu_lof": 7.57944237935e-07, "mu_mis": 6.25185358876e-06, "mu_syn": 2.43449851569e-06, "n_lof": 8.0, "n_mis": 77.0, "n_syn": 26.0, "p_li": 7.57391771227039e-05, "p_null": 0.248208564842618, "p_rec": 0.751715695980259, "syn_z": 0.550179857099254}, "bp": 738, "cds_end": 18149358, "cds_start": 18130898, "n_exons": 8, "nonpsych": {"exp_lof": 10.6421625, "exp_mis": 66.9818275, "exp_syn": 27.8351146, "lof_z": 1.09646903378247, "mis_z": -0.124377243147711, "mu_lof": 7.57944237935e-07, "mu_mis": 6.25185358876e-06, "mu_syn": 2.43449851569e-06, "n_lof": 7.0, "n_mis": 69.0, "n_syn": 23.0, "p_li": 0.000282326682922635, "p_null": 0.235463034039234, "p_rec": 0.764254639277843, "syn_z": 0.576996772181514}, "nontcga": {"exp_lof": 10.96911042, "exp_mis": 68.2364783, "exp_syn": 28.44516604, "lof_z": 1.18219389046069, "mis_z": 0.134885786933328, "mu_lof": 7.57944237935e-07, "mu_mis": 6.25185358876e-06, "mu_syn": 2.43449851569e-06, "n_lof": 7.0, "n_mis": 66.0, "n_syn": 25.0, "p_li": 0.000305481609121487, "p_null": 0.195066053076364, "p_rec": 0.804628465314515, "syn_z": 0.40900507208612}, "transcript": "ENST00000309983.4"}, "exons": [{"cdsend": 18149127, "cdsstart": 18130667, "chr": "6", "position": [[18128313, 18130780], [18132132, 18132177], [18133803, 18133889], [18138962, 18139037], [18139664, 18139717], [18143595, 18143728], [18147822, 18147915], [18148987, 18149171], [18155032, 18155077]], "strand": -1, "transcript": "NM_000367", "txend": 18155077, "txstart": 18128313}, {"cdsend": 18149127, "cdsstart": 18130667, "chr": "6", "position": [[18128313, 18130780], [18132132, 18132177], [18133803, 18133889], [18138962, 18139037], [18139664, 18139717], [18143595, 18143728], [18147822, 18147915], [18148987, 18149171], [18150274, 18150653], [18155032, 18155169]], "strand": -1, "transcript": "NM_001346817", "txend": 18155169, "txstart": 18128313}, {"cdsend": 18149127, "cdsstart": 18130667, "chr": "6", "position": [[18128313, 18130780], [18133803, 18133889], [18138962, 18139037], [18139664, 18139717], [18143595, 18143728], [18147822, 18147915], [18148987, 18149171], [18155032, 18155169]], "strand": -1, "transcript": "NM_001346818", "txend": 18155169, "txstart": 18128313}], "exons_hg19": [{"cdsend": 18149358, "cdsstart": 18130898, "chr": "6", "position": [[18128544, 18131011], [18132363, 18132408], [18134034, 18134120], [18139193, 18139268], [18139895, 18139948], [18143826, 18143959], [18148053, 18148146], [18149218, 18149402], [18155263, 18155308]], "strand": -1, "transcript": "NM_000367", "txend": 18155308, "txstart": 18128544}, {"cdsend": 18149358, "cdsstart": 18130898, "chr": "6", "position": [[18128544, 18131011], [18132363, 18132408], [18134034, 18134120], [18139193, 18139268], [18139895, 18139948], [18143826, 18143959], [18148053, 18148146], [18149218, 18149402], [18150505, 18150884], [18155263, 18155400]], "strand": -1, "transcript": "NM_001346817", "txend": 18155400, "txstart": 18128544}, {"cdsend": 18149358, "cdsstart": 18130898, "chr": "6", "position": [[18128544, 18131011], [18134034, 18134120], [18139193, 18139268], [18139895, 18139948], [18143826, 18143959], [18148053, 18148146], [18149218, 18149402], [18155263, 18155400]], "strand": -1, "transcript": "NM_001346818", "txend": 18155400, "txstart": 18128544}], "generif": [{"pubmed": 10751626, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 11007234, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 11025471, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 11422006, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 11503013, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 11927101, "text": "Defective methylation and subsequent hyperhomocysteinemia leading to impairment of thiopurine methyltransferase activity may serve as a MS susceptibility factor."}, {"pubmed": 11927834, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12142782, "text": "Observational study of genotype prevalence, gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12142782, "text": "Polymorphisms in TPMT are associated with acute lymphoblastic leukemia in Asians and whites"}, {"pubmed": 12172211, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12176518, "text": "Azathioprine toxicity is related to enzyme genotype (and mutation) in renal transplant patients."}, {"pubmed": 12217596, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12492733, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12509611, "text": "Observational study of genotype prevalence, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12563179, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12703994, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12732844, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12777968, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 12777968, "text": "polymorphisms of thiopurine methyltransferase were studied in 306 healthy Brazilians who were classed, on the basis of self-declared colour and ancestry"}, {"pubmed": 12814450, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12815366, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12815366, "text": "This study is the first analysis of TPMT mutant allele frequency in a sample of the Brazilian population."}, {"pubmed": 12880540, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12903038, "text": "Allele frequency of TPMT*3C is low among Jing Chinese (1.0%), and TPMT*3C appears to be the most prevalent deleterious allele in this population."}, {"pubmed": 12903038, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12940924, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12949626, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12972954, "text": "The pharmacogenetics of TPMT was studied in relation to drug toxicity and therapeutic efficacy."}, {"pubmed": 14508387, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 14576848, "text": "REVIEW: pharmacogenetics of TPMT in cancer therapy"}, {"pubmed": 14634700, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 14656901, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 14723818, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14985890, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 14985890, "text": "Thiopurine S-methyltransferase (TPMT) polymorphisms have been linked with severe and potentially fatal myelosuppression in deficient metabolizers and rejection of transplanted organs in high metabolizers."}, {"pubmed": 14985891, "text": "Allelic variation at the TPMT (thiopurine S-methyltransferase) locus resulted in large inter-individual differences in the activity of enzyme TPMT, which the gene encodes and which are responsible for differences in toxicity/efficacy of thiopurine drugs."}, {"pubmed": 14985891, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15022030, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15206995, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15226671, "text": "Polymorphism affects pharmacogenetics. (review)"}, {"pubmed": 15226673, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15226673, "text": "Provides solid basis to predict TPMT phenotype in a Northern European Caucasian population by molecular diagnostics."}, {"pubmed": 15247157, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 15255798, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15349717, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15349717, "text": "When azathioprine is administered at an initial dose of 1.5 mg/kg per day, both coding and promoter TPMT polymorphisms influence the dose tolerated."}, {"pubmed": 15385838, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15476481, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15476481, "text": "TPMT genotype was an independent predictor for hemoglobin, hematocrit and red blood cell changes during azathioprine treatment after kidney transplantation."}, {"pubmed": 15571264, "text": "thiopurine methyltransferase polymorphisms modify the metabolism of the thiopurine drugs [review]"}, {"pubmed": 15571267, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15571267, "text": "TPMT promoter Variable Number Tandem Repeats are unlikely to play a significant role in changes in TPMT activity in response to azathioprine therapy"}, {"pubmed": 15691505, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 15709212, "text": "Specific genetic polymorphisms in drug metabolizing enzymes such as TPMT, drug transporters (MDR1), and drug target enzymes (TS) are associated with clinical outcomes in patients treated with chemotherapy drugs, such as 5-fluorouracil and irinotecan."}, {"pubmed": 15784872, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15784872, "text": "TPMT genotype has a substantial impact on minimal residual disease after administration of mercaptopurine in the early course of childhood ALL, most likely through modulation of mercaptopurine dose intensity."}, {"pubmed": 15792824, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15802809, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 15931768, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15946151, "text": "Genotyping for the major TPMT variant alleles may be valuable tool in preventing azathioprine toxicity."}, {"pubmed": 15967990, "text": "there is a unique pharmacogenetic mechanism by which common polymorphisms affect TPMT protein function and therapeutic response to thiopurine drugs"}, {"pubmed": 15973722, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15973722, "text": "TPMT, ITPA, and MTHFR genotypes do not predict adverse drug reactions, including bone marrow suppression, in liver transplant patients. Possible association between nodular regenerative hyperplasia and heterozygous TPMT genotype."}, {"pubmed": 16006997, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16044099, "text": "Genotyping for the major TPMT variant alleles may be valuable tool in preventing azathioprine toxicity."}, {"pubmed": 16044099, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16164497, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16166171, "text": "Observational study of genotype prevalence, gene-disease association, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16202677, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16214825, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16272700, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16306100, "text": "polymorphisma in the 5,10-methylenetetrahydrofolate reductase gene may play an important role in determing the erythrocyte thiopurine methyltransferase phenotype"}, {"pubmed": 16396707, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16418693, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16431304, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16459728, "text": "Importance of performing surveillance testing for allelic characterization prior to treatment with azathioprine for multiple sclerosis."}, {"pubmed": 16476125, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16595084, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16611274, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16643135, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 16691038, "text": "Observational study of genotype prevalence, gene-disease association, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16724002, "text": "Observational study of genotype prevalence and genetic testing. (HuGE Navigator)"}, {"pubmed": 16773681, "text": "The only discovery translated until now into daily practice is the relation between thiopurine S-methyltransferase (TPMT) gene polymorphisms and hematological toxicity of thiopurine treatment in inflammatory bowel diseases (IBD)."}, {"pubmed": 16789994, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16876902, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16917910, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16946561, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16946561, "text": "Three novel single nucleotide polymorphisms (SNPs) of thiopurine S-methyltransferase were identified-106G>A in exon 3 (Gly36Ser, *20 allele), 967A>G in 3'-untranslated region, and -87C>T in intron 8."}, {"pubmed": 16952345, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17065060, "text": "TPMT does not appear to have a role in response to thiopurine treatment in inflammatory bowel disease"}, {"pubmed": 17113562, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17129980, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17152495, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17164697, "text": "Observational study of genotype prevalence, gene-disease association, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17176368, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17206640, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17220558, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17241387, "text": "Observational study of genotype prevalence and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17241387, "text": "The relationship of TPMT genotype to azathioprine side effects is reported in Japanese patients with autoimmune liver diseases."}, {"pubmed": 17243178, "text": "Structure of TPMT shows that naturally occurring amino acid polymorphisms scatter throughout, & amino acids whose alteration have most influence on function are those that form intra-molecular stabilizing interactions (mainly van der Waals contacts)."}, {"pubmed": 17323057, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17617792, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 17617792, "text": "study provides the first data on the frequency of common TPMT variants in the Turkish population, based on analysis of pediatric patients with acute lymphoblastic leukemia"}, {"pubmed": 17690215, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 17885628, "text": "The novel variant allele of TPMT affects enzyme activity, as the individuals carrying it had almost undetectable TPMT activity."}, {"pubmed": 17909762, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 17919375, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18021342, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18188716, "text": "Thiopurine S-methyltransferase gene (TMPT) polymorphisms in a Mexican population of healthy individuals and leukemic patients."}, {"pubmed": 18193212, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18303966, "text": "A higher prevalence of TPMT deficiency was recorded than in previous studies. Afro-Caribbeans have lower activity than Caucasians and South Asians. TPMT enzyme activity was lower among females, especially in South Asians."}, {"pubmed": 18385010, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 18408566, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18408566, "text": "Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity."}, {"pubmed": 18467186, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18482735, "text": "The A80P polymorphism in TPMT*2 disrupts helix alpha3 bordering the active site, which breaks several salt-bridge interactions and opens up a large cleft in the protein. The A154T polymorphism is located within the co-substrate binding site."}, {"pubmed": 18484748, "text": "Either Arg152 or Arg226 may participate in the TPMT reaction, with one residue compensating when the other is altered, and Arg152 may interact with substrate more directly than Arg226."}, {"pubmed": 18600549, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18600549, "text": "the frequency of functional gene polymorphisms in 396 patients with inflammatory bowel disease and 300 healthy subjects"}, {"pubmed": 18602085, "text": "Identification and functional characterisation of four novel TPMT allelic variants."}, {"pubmed": 18605963, "text": "detected in an Estonoian population were 3 novel mutations -30T>A exon 3, 10A>G intron 3 & 145A>G intron 10; 4 markers whose frequencies were significantly different in intermediate methylators; 1 haplotype associated with intermediate TPMT activity"}, {"pubmed": 18616518, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18693152, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18708949, "text": "analysis of thiopurine S-methyltransferase allelic variants"}, {"pubmed": 18775689, "text": "Observational study of genotype prevalence and genetic testing. (HuGE Navigator)"}, {"pubmed": 18823306, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18827410, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18827410, "text": "TPMT mutations are not associated with myelosuppression in Japanese IBD patients. Even in IBD patients with a wild TPMT genotype, clinicians should pay attention for the possible development of myelosuppression."}, {"pubmed": 18987654, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18987654, "text": "Risk of relapse was higher for the 526 TPMT wild type patients than for the remaining 75 patients. Despite this, patients with low TPMT did not have superior survival possibly due to an excess of secondary cancers among these patients."}, {"pubmed": 18987660, "text": "Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-Mercaptopurine related toxicities in childhood ALL patients."}, {"pubmed": 18987660, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19034904, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19034904, "text": "found no significant association between TPMT SNPs and ALL treatment outcome; TPMT*3A is the most prevalent variant allele in the Russian Federation."}, {"pubmed": 19048244, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 19048245, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19057372, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19057372, "text": "The frequency of allele variants of gene TPMT*2, *3A, *3B, and *3C was estimated in a population of 116 Brazilian children with acute lymphoblastic leukemia."}, {"pubmed": 19164342, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 19177822, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19214663, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19229528, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19239109, "text": "(Heterozygosity, PD, PIC, PE) of TPMT minisatellite locus showed that this marker is informative and can be used for DNA typing and population studies besides being used in clinical investigation in checking thiopurine drug sensitivity of individuals."}, {"pubmed": 19239109, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 19252404, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19252404, "text": "We have demonstrated no significant association between TPMT variant alleles and adverse effects in Han Chinese IBD patients, so the prediction of AZA-related toxicity by TPMT genotyping remains imperfect."}, {"pubmed": 19343046, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19473575, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19474452, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 19535798, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19543639, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 19543639, "text": "The allele TPMT*3A, is the most prevalent in Chilean blood donors, as in Caucasian populations."}, {"pubmed": 19546880, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 19579612, "text": "Adverse reactions to thiopurines in IBD may be predisposed by thiopurine methyltransferase (TPMT) or inosine triphosphate pyrophosphatase (ITPA) gene mutation. Allele frequencies of TPMT*2, TPMT*3A, TPMT*3B, and TPMT*3C were 0, 0, 0, and 0.010 (17/1624)."}, {"pubmed": 19650826, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19675376, "text": "Observational study of genotype prevalence and genetic testing. (HuGE Navigator)"}, {"pubmed": 19682085, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19682195, "text": "Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease."}, {"pubmed": 19682195, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19695401, "text": "In these kidney transplant recipients, patients who carried the TPMT*3C allele were at a higher risk for azathioprine-induced myelosuppression than noncarriers"}, {"pubmed": 19695401, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19748501, "text": "Data show that MTHFR and TYMS genotypes influence TPMT activity, and that males and females demonstrate differential modulation of TPMT activity."}, {"pubmed": 19748501, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19774638, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19830600, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19830600, "text": "TPMT polymorphisms are not associated with 6-mercaptopurine toxicity in precursor B acute lymphoblastic leukemia."}, {"pubmed": 19891552, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19898482, "text": "the strong associations of cisplatin-induced hearing loss with specific genetic variants in TPMT were identified"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19956635, "text": "Uncategorized study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20017316, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20017316, "text": "Two novel heterozygote mutations, 210C>T (C70C, silent) and 622T>C (F208L), were identified in the coding region of the TPMT in Chinese children with acute leukemia."}, {"pubmed": 20037211, "text": "Observational study of gene-disease association and genetic testing. (HuGE Navigator)"}, {"pubmed": 20066544, "text": "TPMT testing before starting a regimen of azathioprine in combination with N-acetylcysteine and steroids in idiopathic pulmonary fibrosis can predict likelihood of leukopenia."}, {"pubmed": 20081263, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20081263, "text": "Thiopurines administration is related to the increase in hemato-oncological treatment toxicity in TPMT heterozygotes."}, {"pubmed": 20136357, "text": "This meta-analysis suggests that individuals with both intermediate and absent TPMT activity have an increased risk of developing thiopurine-induced myelosuppression--REVIEW"}, {"pubmed": 20136364, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 20153897, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20153897, "text": "Thiopurine S-methyltransferase gene polymorphism is associated with less 6-mercaptopurine dose intensity in acute lymphoblastic leukemia."}, {"pubmed": 20173083, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 20175804, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 20175804, "text": "approximately 1 in 180 persons born in Mexico City might have low or undetectable TPMT enzyme activity."}, {"pubmed": 20175817, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20308917, "text": "Data showed that it could be helpful to examine TPMT genotypes and to measure TPMT activity in Korean patients taking AZA/6-MP to predict the development of leukopenia."}, {"pubmed": 20308917, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20349237, "text": "Case Report: invasive aspergillosis concomitant with azathioprine-induced leucopenia without carrying any TPMT mutant allele."}, {"pubmed": 20350137, "text": "Both the number and type of VNTRs, as well as the upstream regulatory region of the TPMT gene promoter, determine the overall level of TPMT gene transcription."}, {"pubmed": 20350137, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20393862, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20403997, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20408054, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 20521035, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 20593505, "text": "Meta-analysis of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20881512, "text": "Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene"}, {"pubmed": 20945351, "text": "novel mutation, TPMT c.349>A,resulting in the amino acid substitution p.117G>R, caused misdiagnosis of TPMT deficiency"}, {"pubmed": 20972624, "text": "A patient carrying TPMT*3C polymorphism is diagnosed with azathioprine-induced severe cholestatic hepatitis."}, {"pubmed": 21254844, "text": "The distribution of NAT2, TPMT, and MTHFR gene polymorphisms in Baja California, Mexico exhibited allele and genotype frequencies that are highly similar to those observed in Caucasian populations."}, {"pubmed": 21348397, "text": "Thioguanides family of drugs can cause life-threatening myelosuppression due to low activity of a critical metabolic enzyme, thiopurine S-methyl transferase"}, {"pubmed": 21819368, "text": "Frequency of thiopurine S-methyltransferase gene mutations is low among Iranian kidney transplant patients. The incidence of adverse reactions to azathioprine was also low."}, {"pubmed": 21938428, "text": "Distributions of TPMT genotype and allele frequency in Iranian populations are different from the genetic profile found among Caucasian or Asian populations."}, {"pubmed": 22225964, "text": "This study provides the first analysis of TPMT mutant allele frequency in individuals of Tunisian origin"}, {"pubmed": 22304581, "text": "6-mercaptopurine (6-MP) treatment results in a VNTR architecture-dependent decrease of TPMT gene transcription."}, {"pubmed": 22318545, "text": "The distribution of TPMT, UGT1A1 and MDR1 gene polymorphisms of the South Indian population was significantly different from other populations."}, {"pubmed": 22385887, "text": "Inflammatory bowel disease patients may have significantly higher prevalence of TPMT polymorphism and, even more, low activity."}, {"pubmed": 22486532, "text": "High TPMT enzyme activity does not explain drug resistance Many of these patients preferentially produce the toxic 6-methylmercaptopurine metabolites (6-MMP) rather than the active 6-thioguanine nucleotides (6-TGN)"}, {"pubmed": 22594254, "text": "TPMT activity was measured in RBC by HPLC method."}, {"pubmed": 22616585, "text": "aim of this study was to determine the frequency of the four most common allelic variants of TPMT gene in the population of Slovak IBD patients.TPMT genetic polymorphisms lead to dose-related hematopoetic toxicity"}, {"pubmed": 22747506, "text": "TPMT*2 allelic variant displays a protected region in the C-terminus, which differs from wild-type TPMT, whereas the protected regions in TPMT*5 allele are located mainly in the N-terminus close to the active site."}, {"pubmed": 22846425, "text": "These data indicate that polymorphism in PACSIN2 significantly modulates TPMT activity and influences the risk of GI toxicity associated with mercaptopurine therapy."}, {"pubmed": 22931646, "text": "Severe intolerance to 6-mercaptopurine in children with acute lymphoblastic leukemia might be not related with the mutation of coding region in TPMT gene."}, {"pubmed": 22972540, "text": "TPMT kd cells were more sensitive to 6-mercaptopurine (6-MP) (10 mumol/L) and 6-thioguanine (6-TG) (8 mumol/L) than wild-type (wt) cells, (32% versus 20%) and (18% versus 9%), respectively."}, {"pubmed": 23014567, "text": "observed influence of the TMPT-genotype on MRD in patients with precursor B-ALL before application of mercaptopurines suggests a direct connection to the physiological role of TPMT"}, {"pubmed": 23025308, "text": "The study focused on explaining how a locally occurred TPMT A167G substitution propagated through hydrogen bonds alteration to induce structural modification which affects both thiopurine and S-adenosylmethionine receptors."}, {"pubmed": 23065291, "text": "The G238C and A719G single nucleotide polymorphisms in the human TPMT gene are not associated with increased risk of developing acute lymphoblastic leukemia."}, {"pubmed": 23126166, "text": "SNP of TPMT (TPMT*3C) is recognized in only 1-2% of Japanese and its ill effect among them is difficult to surmise."}, {"pubmed": 23192017, "text": "Letter/Case Report: TPMT monitoring is unable to predict azathiopurine-associated non-myelotoxicity."}, {"pubmed": 23252704, "text": "Based on the HRMA and sequencing in the investigated group, two most frequent alleles for the Caucasian population were found: TPMT*1 with the frequency of 96.72% and TPMT*3A with the frequency of 3.28%.in this study of the polish population."}, {"pubmed": 23252716, "text": "In childhood acute lymphoblastic leukaemia, TPMT activity should not be used to predict heterozygosity particularly in blood samples obtained at disease diagnosis"}, {"pubmed": 23377985, "text": "this is the first study that assesses the TPMT variant allele frequencies in Guatemalan populations"}, {"pubmed": 23398787, "text": "identify the most common genetic polymorphisms of TPMT in healthy Jordanian volunteers and patients with rheumatoid arthritis"}, {"pubmed": 23400745, "text": "In a study of Italian myasthenia gravis patients treated with azathioprine, a new TPMT haplotype, TPMT* 3E, was observed only in association with intolerance."}, {"pubmed": 23553048, "text": "TPMT*3A and the TPMT*3C, which cause the largest decrease in enzyme activity, were both variant alleles detected in the Tunisian population"}, {"pubmed": 23581716, "text": "distribution of the most frequent variants of TPMT gene was similar in a healthy population and patients with inflammatory bowel disease"}, {"pubmed": 23588304, "text": "A predictive model combining variants in TPMT, ABCC3, and COMT with clinical variables significantly improved the prediction of hearing-loss development as compared with using clinical risk factors alone"}, {"pubmed": 23731044, "text": "This study shows the prevalence of TPMT genetic polymorphisms in population of Slovak IBD patients"}, {"pubmed": 23811272, "text": "differential contribution of the enzyme TPMT to the cytotoxicity of the two thiopurines is probably due to its role in formation of the meTIMP, the cytotoxic methylated metabolite of 6-MP"}, {"pubmed": 23820299, "text": "our results indicated that TPMT or COMT genetic variation was not related to cisplatin ototoxicity in children with cancer and did not influence cisplatin-induced hearing damage in laboratory models"}, {"pubmed": 23844534, "text": "A high frequency and diversity of variant TPMT genotypes was found in this series with predominance of the TPMT*3B allele"}, {"pubmed": 23996738, "text": "plays a key role in the metabolism of azathioprine/6- mercaptopurine (6-MP). Mutations in the enzyme lead to generation of excess thioguanine, which causes neutropenia via suppression of neutrophils."}, {"pubmed": 24121523, "text": "Heart transplantation recipients with TPMT genetic variant alleles who are treated with AZA develop acute rejection earlier, more frequently, and of greater severity."}, {"pubmed": 24322830, "text": "TPMT*3c mutant allele was associated with azathioprine side effects (leukopenia, alopecia) in Chinese systemic lupus erythematosus patients."}, {"pubmed": 24643197, "text": "Activity measurement performed at diagnosis provides clinicians with information on immediate pharmacokinetic-related adverse events and/or hypermetabolism"}, {"pubmed": 24696613, "text": "The prevalence of TPMT genotypes was high among Brazilian patients. Variants genes 2 and 3C may be associated with azathioprine pancreatic toxicity in a IBD southeastern Brazilian population"}, {"pubmed": 24710034, "text": "TPMT*37 introduces a premature stop codon at position 216, resulting in loss of the last 29 amino acid residues from the C terminal of the TPMT protein."}, {"pubmed": 24737678, "text": "suggest that germline genetic variation in TPMT and MTHFR do not significantly alter SOS risk in patients exposed to thioguanine"}, {"pubmed": 24774509, "text": "TMPT genotyping appears an important tool to further optimize 6-MP treatment design in Chilean patients with ALL"}, {"pubmed": 25347948, "text": "Data suggest risk of myelotoxicity of high-dose methotrexate during methotrexate/6-mercaptopurine maintenance chemotherapy of childhood acute leukemia is not associated with heterozygosity in thiopurine methyltransferase in Nordic population studied."}, {"pubmed": 25551397, "text": "this paper shows that the influence of TPMT and COMT on the development of cisplatin-induced hearing loss may be less important than previously suggested."}, {"pubmed": 25564374, "text": "Results show complete sequence-based screening study evaluating all TPMT variants in Asian populations some of them may ne of relevance in Korean population."}, {"pubmed": 25799415, "text": "association of TPMT polymorphisms with overall thiopurine-induced adverse drug reactions"}, {"pubmed": 25819542, "text": "We report on the presence of the TPMT*3C and *3A mutant alleles in the Libyan population. Therefore, monitoring the patients to be treated with doses of thiopurine drugs for TPMT variants is worthwhile to avoid the development of severe myelosuppression."}, {"pubmed": 25940902, "text": "refinements in risk stratification and treatment have reduced the influence of TPMT genotype on treatment outcome in a contemporary protocol."}, {"pubmed": 26072396, "text": "Identification of TPMT variants and subsequent dose reduction reduces hematologic events during thiopurine treatment of inflammatory bowel disease."}, {"pubmed": 26410243, "text": "structure-function relationships of TPMT"}, {"pubmed": 26411491, "text": "The TPMT promoter region may serve as a pharmacogenomic biomarker when introducing thiopurine therapy"}, {"pubmed": 26633017, "text": "Association of TPMT polymorphisms with overall azathioprine-induced adverse drug reactions, bone marrow toxicity and gastric intolerance, but not with hepatotoxicity (meta-analysis)."}, {"pubmed": 26674571, "text": "The aim of the study was to investigate frequencies of TPMT and ITPA polymorphisms in Lithuanian inflammatory bowel disease patients and analyze their association with azathioprine-related adverse events."}, {"pubmed": 26845729, "text": "With respect to TPMT, the variants TPMT*2 and TPMT*3A were not implicated in genetic susceptibility to childhood acute lymphoblastic leukemia"}, {"pubmed": 26974142, "text": "A point mutation in the thiopurine S-methyltransferase gene that led to exon 5 deletion in the transcribed mRNA."}, {"pubmed": 27217052, "text": "Review/Meta-analysis: thiopurine S-methyltransferase testing for averting drug toxicity."}, {"pubmed": 27333713, "text": "The most frequently occurring nonfunctional TPMT allele in Croatian population is TPMT*3A. Variant genotypes were statistically significantly more common in Crohn's disease subgroup than in ulcerative colitis subgroup."}, {"pubmed": 27453281, "text": "The aims of this research were to investigate the association of TPMT phenotypes with MDR1 genotypes."}, {"pubmed": 27564568, "text": "In a GWAS, TPMT activity in patients behaves as a monogenic trait, further bolstering the utility of TPMT genetic testing in the clinic"}, {"pubmed": 27577869, "text": "TMPT polymorphisms are associated with 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia."}, {"pubmed": 27665263, "text": "The frequency of TPMT mutation in a homogeneous Sicilian cohort of patients with inflammatory bowel disease, autoimmune and hematological disorders was low. TPMT genotyping is not a sensitive tool for predicting thiopurine-induced leukopenia."}, {"pubmed": 27703193, "text": "Of the 14 patients intolerant to thiopurines, NGS identified deleterious TPMT variants in 5 individuals whereas the biochemical test identified 8 individuals as intolerant (sensitivity 35.7% and 57.14%; specificity 93.75% and 50% respectively). SKAT-O test identified a significant association between MOCOS gene and TPMT activity (p = 0.0015), not previously reported."}, {"pubmed": 27770449, "text": "meta-analysis of three independent GWAS of TPMT activity; only genetic variants mapping to chromosome 6, including the TPMT gene region, were significantly associated with TPMT activity;finding is consistent with TPMT genotype being the primary determinant of TPMT activity"}, {"pubmed": 28146264, "text": "TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay."}, {"pubmed": 28374975, "text": "genetic association studies in cohort in Denmark: Data suggest that standard immunosuppression treatment failure in patients with autoimmune hepatitis is not associated with thiopurine S-methyltransferase genetic variants or HLA-DRB1*03 genotype in the population studied. (HLA-DRB1 = major histocompatibility complex class II DR beta 1)"}, {"pubmed": 28445188, "text": "Results show no association between TPMT or COMT single-nucleotide polymorphisms and cisplatin-induced ototoxicity."}, {"pubmed": 28476189, "text": "TPMT*3C is overrepresented in acute lymphoblastic leukemia (ALL) cases in comparison with non-ALL group"}, {"pubmed": 28552060, "text": "This article reviews the thiopurine pharmacogenetics and the methods applied in common practice to evaluate patient's TPMT status.  [review]"}, {"pubmed": 28857898, "text": "A statistically significant correlation between the presence of the G460A mutation and the development of leucopenia after the administration of thiopurines was observed."}, {"pubmed": 29191122, "text": "TPMT*3C affects TPMT activity in Chinese patients with neuromyelitis optica spectrum disorders."}, {"pubmed": 29206869, "text": "study aimed to determine the relationship between thiopurine metabolite levels and therapeutic response, and to investigate the association of NUDT15, TPMT, and thiopurine metabolites with leukopenia in patients with CD"}, {"pubmed": 29264794, "text": "In Mexican patients, mutant alleles were detected in 6.2 and 5.2% of systemic lupus erythematosus and rheumatoid arthritis cases, respectively."}, {"pubmed": 29321348, "text": "Patients also developed infection who mostly (71%) needed hospitalization. None of the studied G238C, G460A and A719G TPMT variant alleles were detected. Infections and febrile neutropenia were common causes of 6-PM dose modification and interruption."}, {"pubmed": 29491687, "text": "Mutation rate of NUDT15 in Chinese inflammatory bowel disease patients is higher than that of TPMT. NUDT15 polymorphism is a better predictor for AZA-induced leukopenia than TPMT polymorphism."}, {"pubmed": 29630648, "text": "ANCA associated vasculitis (AAV) patients treated with cyclophosphamide induction and azathioprine maintenance therapy were included and followed for 60 months. TPMT genotype and activity were not independent predictors of relapse, and could not predict leukopenia or other adverse effects from azathioprine."}, {"pubmed": 29659353, "text": "The presence of *2, *3A, *3B and *3C mutations were determined, and the relationship between genotype and incidence of adverse events related to the drug was analyzed.Nine carried at least one non-functional allele. Among the eighteen patients who initiated treatment with azathioprine, toxicity was detected in 3 cases: 2 mild events were observed in patients with normal genotype, and one serious was a homozygous patient."}, {"pubmed": 30308221, "text": "TPMT has a role in methylation of selenium compounds"}, {"pubmed": 30325120, "text": "Frequency of TPMT alleles increases the efficacy of leukemia treatment. Thus, TPMT genotyping can be useful for optimizing 6-MP therapy."}, {"pubmed": 30345902, "text": "The stepwise evolution of TPMT*3 alleles from *3C to *3A, with increasing number of B motifs in the VNTR region."}, {"pubmed": 30477053, "text": "In our study patients even with wild type TPMT genotype (17.5%) developed myelosuppression underscoring the importance of TPMT mutation as the only factor contributing to myelosuppression"}, {"pubmed": 30686035, "text": "Regular blood tests are necessary on thiopurine therapy despite normal thiopurine S-methyltransferase genotype because of the risk of myelosuppression. The four most common variant alleles were identified in routine genotyping only, therefore most likely rare variant allele(s) or polymorphism of other enzymes involved in thiopurine metabolism account for the aforementioned four cases with profound bone marrow suppression."}, {"pubmed": 30728528, "text": "As expected TPMT was the main cause of severe hematotoxicity in 31% of patients, who were either TPMT deficient (10%) or heterozygous carriers of TPMT variants (21%). By comparison, NUDT15 genetic polymorphism was identified in 14 (13%) patients including one novel variant (p.Met1Ile). Six percent of patients with severe toxicity carried variants in both TPMT and NUDT15."}, {"pubmed": 30806759, "text": "TPMT*3C and TPMT*12 are the key determinants of 6-mercaptopurine-mediated hematological toxicity in acute lymphoblastic leukemia patients"}, {"pubmed": 30945335, "text": "Optimizing thiopurine dosing based on TPMT and NUDT15 genotypes."}, {"pubmed": 31387318, "text": "In patients with inflammatory bowel diseases (IBD), the use of azathioprine results in adverse events at a rate of 5% to 20%. The aim of the study was to assess a possible correlation between genetic variability of the enzyme thiopurine S-methyltransferase (TPMT) and the development of toxicity to azathioprine."}, {"pubmed": 31556692, "text": "The TPMT*3C and NUDT15*3 genotypes were significantly associated with azathioprine-induced leukopenia in Chinese patients with rheumatic diseases. In addition, NUDT15*3 was significantly associated with gastrointestinal effects, erythropenia, hypochromia, and thrombocytopenia. The TPMT*3C genotypes were also significantly associated with gastrointestinal discomfort, alopecia, and hypochromia."}, {"pubmed": 31635813, "text": "We evaluated the role of thiopurine methyltransferase (TPMT) in 6-mercaptopurine (6-MP) sensitivity during treatment of pediatric patients with acute lymphoblastic leukemia"}, {"pubmed": 31639757, "text": "Retrospective Data Analysis of the Influence of Age and Sex on TPMT Activity and Its Phenotype-Genotype Correlation."}, {"pubmed": 32187056, "text": "Association of thiopurine S-methyltransferase and NUDT15 polymorphisms with azathioprine-induced myelotoxicity in Chinese patients with rheumatological disease."}, {"pubmed": 32453263, "text": "Pharmacogenomics of thiopurines: distribution of TPMT and NUDT15 polymorphisms in the Brazilian Amazon."}, {"pubmed": 32992962, "text": "Association between the TPMT*3C (rs1142345) Polymorphism and the Risk of Death in the Treatment of Acute Lymphoblastic Leukemia in Children from the Brazilian Amazon Region."}, {"pubmed": 33111378, "text": "NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India."}, {"pubmed": 33118454, "text": "Identification of rare defective allelic variants in cases of thiopurine S-methyltransferase deficient activity."}, {"pubmed": 33229787, "text": "Thiopurine S-methyltransferase Genetic Polymorphism and Its Contribution for Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients: A Summative Analysis."}, {"pubmed": 33846471, "text": "Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis."}, {"pubmed": 33928426, "text": "No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study."}, {"pubmed": 34425754, "text": "TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India."}, {"pubmed": 34582038, "text": "TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results."}, {"pubmed": 35045652, "text": "[Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia]."}, {"pubmed": 35431360, "text": "Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia."}, {"pubmed": 35538648, "text": "Molybdenum Cofactor Catabolism Unravels the Physiological Role of the Drug Metabolizing Enzyme Thiopurine S-Methyltransferase."}, {"pubmed": 36917731, "text": "Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children."}, {"pubmed": 36946340, "text": "TPMT gene polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a healthy Venezuelan population."}, {"pubmed": 37556121, "text": "The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs."}, {"pubmed": 37865284, "text": "Transcriptome analysis reveals involvement of thiopurine S-methyltransferase in oxidation-reduction processes."}, {"pubmed": 38159853, "text": "Differential molecular mechanisms of substrate recognition by selenium methyltransferases, INMT and TPMT, in selenium detoxification and excretion."}], "genomic_pos": {"chr": "6", "end": 18155077, "ensemblgene": "ENSG00000137364", "start": 18128311, "strand": -1}, "genomic_pos_hg19": {"chr": "6", "end": 18155305, "start": 18128542, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0006139", "pubmed": 8316220, "qualifier": "involved_in", "term": "nucleobase-containing compound metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006805", "pubmed": [657528, 18484748], "qualifier": "involved_in", "term": "xenobiotic metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006805", "qualifier": "involved_in", "term": "xenobiotic metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0032259", "qualifier": "involved_in", "term": "methylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0042178", "qualifier": "involved_in", "term": "xenobiotic catabolic process"}], "CC": {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32814053, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008119", "qualifier": "enables", "term": "thiopurine S-methyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008119", "pubmed": [657528, 18484748], "qualifier": "enables", "term": "thiopurine S-methyltransferase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008119", "qualifier": "enables", "term": "thiopurine S-methyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:1904047", "pubmed": [657528, 18484748], "qualifier": "enables", "term": "S-adenosyl-L-methionine binding"}]}, "homologene": {"genes": [[7955, 436842], [7955, 573111], [8364, 549164], [9031, 420830], [9544, 704564], [9598, 471863], [9606, 7172], [9615, 403536], [9913, 511644], [10090, 22017], [10116, 690050]], "id": 313}, "interpro": [{"desc": "TPMT family", "id": "IPR008854", "short_desc": "TPMT"}, {"desc": "Thiopurine S-methyltransferase", "id": "IPR025835", "short_desc": "Thiopurine_S-MeTrfase"}, {"desc": "S-adenosyl-L-methionine-dependent methyltransferase superfamily", "id": "IPR029063", "short_desc": "SAM-dependent_MTases_sf"}], "ipi": "IPI00019400", "map_location": "6p22.3", "name": "thiopurine S-methyltransferase", "other_names": ["S-adenosyl-L-methionine:thiopurine S-methyltransferase", "thiopurine S-methyltransferase"], "pantherdb": {"HGNC": "12014", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "98812", "ortholog_type": "LDO", "panther_family": "PTHR10259", "taxid": 10090, "uniprot_kb": "O55060"}, {"RGD": "1585162", "ortholog_type": "LDO", "panther_family": "PTHR10259", "taxid": 10116, "uniprot_kb": "Q9Z0T0"}, {"Ensembl": "ENSGALG00000012687", "ortholog_type": "LDO", "panther_family": "PTHR10259", "taxid": 9031, "uniprot_kb": "F1NGW2"}, {"ZFIN": "ZDB-GENE-041010-177", "ortholog_type": "O", "panther_family": "PTHR10259", "taxid": 7955, "uniprot_kb": "F8W621"}, {"ZFIN": "ZDB-GENE-050522-141", "ortholog_type": "LDO", "panther_family": "PTHR10259", "taxid": 7955, "uniprot_kb": "Q504A5"}], "uniprot_kb": "P51580"}, "pathway": {"kegg": {"id": "hsa00983", "name": "Drug metabolism - other enzymes - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-156580", "name": "Phase II - Conjugation of compounds"}, {"id": "R-HSA-156581", "name": "Methylation"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-211859", "name": "Biological oxidations"}, {"id": "R-HSA-5578995", "name": "Defective TPMT causes TPMT deficiency"}, {"id": "R-HSA-5579029", "name": "Metabolic disorders of biological oxidation enzymes"}, {"id": "R-HSA-5668914", "name": "Diseases of metabolism"}, {"id": "R-HSA-9748784", "name": "Drug ADME"}, {"id": "R-HSA-9748787", "name": "Azathioprine ADME"}], "smpdb": [{"id": "SMP00427", "name": "Azathioprine Action Pathway"}, {"id": "SMP00428", "name": "Mercaptopurine Action Pathway"}, {"id": "SMP00430", "name": "Thioguanine Action Pathway"}, {"id": "SMP00609", "name": "Mercaptopurine Metabolism Pathway"}], "wikipathways": [{"id": "WP702", "name": "Metapathway biotransformation Phase I and II"}, {"id": "WP704", "name": "Methylation Pathways"}]}, "pdb": ["2BZG", "2H11"], "pfam": "PF05724", "pharmgkb": "PA356", "pharos": {"target_id": 6917, "tdl": "Tchem"}, "pir": "I57946", "prosite": "PS51585", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF229811", "relationship": "is"}, {"id": "GNF257495", "relationship": "is"}, {"id": "GNF257496", "relationship": "is"}, {"id": "GNF257497", "relationship": "is"}, {"id": "GNF257498", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": [{"id": "GNF158570", "relationship": "is"}, {"id": "GNF159478", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF032496", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF091413", "relationship": "is"}, {"id": "GNF091414", "relationship": "is"}, {"id": "GNF091415", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053703", "relationship": "is"}, {"id": "GNF058475", "relationship": "is"}, {"id": "GNF073702", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069989", "relationship": "is"}, {"id": "GNF069990", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF014848", "relationship": "is"}, {"id": "GNF014849", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF111585", "relationship": "is"}, {"id": "GNF151226", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000006.12", "NC_060930.1", "NG_012137.3"], "protein": ["NP_000358.1", "NP_001333746.1", "NP_001333747.1", "XP_047275245.1", "XP_047275246.1", "XP_054212273.1", "XP_054212274.1"], "rna": ["NM_000367.5", "NM_001346817.1", "NM_001346818.1", "XM_047419289.1", "XM_047419290.1", "XM_054356298.1", "XM_054356299.1"], "translation": [{"protein": "XP_047275246.1", "rna": "XM_047419290.1"}, {"protein": "XP_054212273.1", "rna": "XM_054356298.1"}, {"protein": "NP_001333746.1", "rna": "NM_001346817.1"}, {"protein": "NP_000358.1", "rna": "NM_000367.5"}, {"protein": "NP_001333747.1", "rna": "NM_001346818.1"}, {"protein": "XP_047275245.1", "rna": "XM_047419289.1"}, {"protein": "XP_054212274.1", "rna": "XM_054356299.1"}]}, "reporter": {"HG-U133_Plus_2": ["203671_at", "203672_x_at", "238272_at"], "HG-U95Av2": "32810_at", "HTA-2_0": "TC06001301.hg.1", "HuEx-1_0": ["2944025", "3787361", "3787363"], "HuGene-1_1": "8124134", "HuGene-2_1": "17015975"}, "summary": "This gene encodes the enzyme that metabolizes thiopurine drugs via S-adenosyl-L-methionine as the S-methyl donor and S-adenosyl-L-homocysteine as a byproduct. Thiopurine drugs such as 6-mercaptopurine are used as chemotherapeutic agents. Genetic polymorphisms that affect this enzymatic activity are correlated with variations in sensitivity and toxicity to such drugs within individuals, causing thiopurine S-methyltransferase deficiency. Related pseudogenes have been identified on chromosomes 3, 18 and X. [provided by RefSeq, Aug 2014].", "symbol": "TPMT", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1336663"}, "unigene": "Hs.444319", "uniprot": {"Swiss-Prot": "P51580"}, "wikipedia": {"url_stub": "Thiopurine methyltransferase"}}